未登录

B

Brigitte Cheuvart

GlaxoSmithKline

H指数:19

被引数:3,760

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2024-04-300

OAAI

Harmonizing the collection of solicited adverse events in prophylactic vaccine clinical trials

EXPERT REVIEW OF VACCINES

IF4.8

2023-10-090

OA

Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2023-02-062

OAAI

No Consistent Evidence of Decreased Exposure to Varicella-Zoster Virus Among Older Adults in Countries with Universal Varicella Vaccination

在普遍接种水痘疫苗的国家，没有一致的证据表明老年人接触水痘病毒减少

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2021-10-056

OAAI

A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2021-08-241

OAAI

Late Breaking Abstract - Seroprevalence of Bordetella pertussis in chronic obstructive pulmonary disease (COPD) patients

EUROPEAN RESPIRATORY JOURNAL

IF21

2020-10-283

PRE

Association between rotavirus gastroenteritis and intussusception: suggested evidence from a retrospective study in claims databases in the United States

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2020-07-017

OAAI

Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age

1-10岁初次接种menacwy-tt疫苗后的十年抗体持久性和加强反应

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2020-06-2912

OAAI

A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years

BMC INFECTIOUS DISEASES

IF3

2020-06-1810

OAAI

Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2019-01-0419

OAAI

Immunogenicity and safety of the Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine co-administered with human rotavirus, hepatitis A and 13-valent pneumococcal conjugate vaccines: results from a phase III, randomized, multicenter study in infants

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2018-10-055

OAAI

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa

与许可的Infanrix hexa相比，在六价dtpa-hbv-ipv/Hib联合疫苗中使用白喉，破伤风和b型流感嗜血杆菌抗原的2种研究制剂进行初次和加强疫苗接种的免疫原性和安全性

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2017-03-241

OAAI

Persistence clinical studies

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2014-11-030

OAAI

Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis Analysis of clinical trials of human rotavirus vaccine

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2013-11-1353

OAAI

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2010-01-28749

OAAI

Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis b, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine

JOURNAL OF PEDIATRICS

IF3.5

2007-07-0130

OAAI

Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2006-01-051.6K

OA

Ruiz-Palacios, GM; Pérez-Schael, I; Velázquez, FR; Abate, H; Breuer, T; Clemens, SC; Cheuvart, B; Espinoza, F; Gillard, P; Innis, BL; Cervantes, Y; Linhares, AC; López, P; Macías-Parra, M; Ortega-Barría, E; Richardson, V; Rivera-Medina, DM; Rivera, L; Salinas, B; Pavía-Ruz, N; Salmerón, J; Rüttimann, R; Tinoco, JC; Rubio, P; Nuñez, E; Guerrero, ML; Yarzábal, JP; Damaso, S; Tornieporth, N; Sáez-Llorens, X; Vergara, RF; Vesikari, T; Bouckenooghe, A; Clemens, R; De Vos, B; O'Ryan, M